Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 4099-4106

  Miura, Naoko ^a   Yano, Tokujiro ^a   Shoji, Fumihiro ^a   Kawano, Daigo ^a   Takenaka, Tomoyoshi ^a   Ito, Kensaku ^a   Morodomi, Yosuke ^a   Yoshino, Ichiro ^b   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Epithelial mesenchymal transition; Non small cell lung cancer; Sip1; Snail; Twist

Indexed keywords

BETA CATENIN; NERVE CELL ADHESION MOLECULE; SMAD INTERACTING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MESENCHYME CELL; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SMOKING; SURVIVAL TIME; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BETA CATENIN; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MESODERM; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROGNOSIS; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR; VIMENTIN;

EID: 71949088911     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Parkin DM: Global cancer statistics in the year 2000: Lancet Oncol 2: 533-543, 2001.
2. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R et al: The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the fourthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2: 706-714, 2007. (Pubitemid 47357522)
3. Kenny PM, King MT, Viney RC, Boyer MJ, Pollicino CA, McLean JM et al: Quality of life and survival in the 2 years after surgery for non-small cell lung cancer. J Clin Oncol 26: 233-241, 2008.
4. Thiery JP: Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2: 442-454, 2002.
5. Guarino M, Rubino B and Ballabio G: The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39: 305-318, 2007. (Pubitemid 46897605)
6. Kang Y and Massagué J: Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 118: 277-279, 2004. (Pubitemid 39061108)
7. Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
8. Rosivatz E, Becker I, Specht K, Friche E, Luber B, Busch R et al: Differential expression of the epithelial-mesenchymal transition regulators Snail, Sip1, and Twist in gastric cancer. Am J Pathol 161: 1881-1891, 2002.
9. Bindels S, Mestdagt M, Vandewalle C, Jacobs N, Volders L, Noël A et al: Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 25: 4975-4985, 2006. (Pubitemid 44246356)
10. Gravdal K, Halvorsen OJ, Haukaas SA and Akslen LA: A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13: 7003-7011, 2007. (Pubitemid 350276881)
11. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005. (Pubitemid 41267170)
12. Hosono S, Kajiyama H, Terauchi M, Shibata K, Ino K, Nawa A et al: Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br J Cancer 96: 314-320, 2007. (Pubitemid 46160637)
13. Lee TK, Poon RTP, Yuen AP, Ling MT, Kwok WK, Wang XH et al: Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 12: 5369-5376, 2006.
14. Yuen HF, Chua CW, Chan YP, Wong YC, Wang X and Chan KW: Significance of Twist and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology 50: 648-658, 2007. (Pubitemid 46495834)
15. Kyo S, Sakaguchi J, Ohno S, Mizumoto Y, Maida Y, Hashimoto M et al: High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 37: 431-438, 2006.
16. Martin TA, Goyal A, Watkins G and Jiang WG: Expression of the transcription factors Snail, Slug, and Twist and their clinical significance in human breast cancer. Ann Surg Oncol 12: 488-496, 2005.
17. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J et al: Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21: 3241-3246, 2002. (Pubitemid 34548095)
18. Moody SE, Perez D, Pan T, Sarkisian CJ, Portocarrero CP, Sterner CJ et al: The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209, 2005. (Pubitemid 41317591)
19. Natsugoe S, Uchikado Y, Okumura H, Matsumoto M, Setoyama T, Tamotsu K et al: Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep 17: 517-523, 2007.
20. Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I et al: Snail, Slug, and smad-interacting protein1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103: 1631-1643, 2005.
21. Maeda G, Chiba T, Okazaki M, Satoh T, Taya Y, Aoba T et al: Expression of SIP1 in oral squamous cell carcinomas; implication for E-cadherin expression and tumor progression. Int J Oncol 27: 1535-1541, 2005.
22. Comijn J, Berx G, Vermassen P, Verschueren K, Grunsven L, Bruyneel E et al: The two-handed E-box-binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267-1278, 2001. (Pubitemid 32607360)
23. Sobin LH and Wittekind Ch: International Union Against Cancer. TNM Classification of Malignant Tumors. 6th edition. New York, 2002
24. Moon KC, Cho SY, Lee HS, Jeon YK, Chung JH, Jung KC et al: Distinct expression patterns of E-cadherin and β-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma. Arch Pathol Lab Med 130: 1320-1325, 2006.
25. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG et al: Epithelial to mesenchymal transition: expression of the regulators Snail, Slug, and Twist in pancreatic cancer. Clin Cancer Res 13: 4769-4776, 2007.
26. Lee TK, Man K, Poon RT, Lo CM, Yuen AP, Ng IO et al: Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res 66: 9948-9956, 2006. (Pubitemid 44672047)
27. Alves CC, Rosivatz E, Schott C, Hollweck R, Becker I, Sarbia M et al: Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol 211: 507-515, 2007. (Pubitemid 46502426)
28. kip1. J Cell Biol 142: 557-571, 1998. (Pubitemid 28361560)
29. Usami Y, Satake S, Nakayama F, Matsumoto M, Ohnuma K, Komori T et al: Snail-associated epithelial-mesenchymal transition promotes oesphageal squamous cell carcinoma motility and progression. J Pathol 215: 330-339, 2008. (Pubitemid 351956714)